APA (7th ed.) Citation

Toragall, V., Rester, A. C., Begum, S., Shofolawe-Bakare, O. T., Hulugalla, K., Monroe, J. D., . . . Werfel, T. A. (2025). Targeting platelet-tumor cell interactions via thromboxane A2-prostanoid receptor blockade to reduce metastasis in triple negative breast cancer. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00723-7

Chicago Style (17th ed.) Citation

Toragall, Veeresh, Ann C. Rester, Salma Begum, Oluwaseyi T. Shofolawe-Bakare, Kenneth Hulugalla, Jerry D. Monroe, John P. Bentley, Yann Gibert, and Thomas A. Werfel. "Targeting Platelet-tumor Cell Interactions via Thromboxane A2-prostanoid Receptor Blockade to Reduce Metastasis in Triple Negative Breast Cancer." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00723-7.

MLA (9th ed.) Citation

Toragall, Veeresh, et al. "Targeting Platelet-tumor Cell Interactions via Thromboxane A2-prostanoid Receptor Blockade to Reduce Metastasis in Triple Negative Breast Cancer." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00723-7.